We have located links that may give you full text access.
Use of transfer factor in immunosuppressed surgical patients.
Revista do Colégio Brasileiro de Cirurgiões 2017 September
OBJECTIVE : to evaluate the action of Transfer Factor on the immune response of patients with malignant neoplasm submitted to surgery, chemotherapy and radiotherapy.
METHOD: we analyzed the variations of leukocytes, total lymphocytes, T-lymphocytes and CD4 counts in 60 patients submitted to immunostimulation with a single, daily dose of 0.5mg sublingual Transfer Factor, started simultaneously with chemotherapy and/or radiotherapy.
RESULTS: there were statistically significant increases in the counts of all cell lines studied, more pronounced after 12 months of use of the medication.
CONCLUSION: the Transfer Factor restored immune response and showed no side effects.
METHOD: we analyzed the variations of leukocytes, total lymphocytes, T-lymphocytes and CD4 counts in 60 patients submitted to immunostimulation with a single, daily dose of 0.5mg sublingual Transfer Factor, started simultaneously with chemotherapy and/or radiotherapy.
RESULTS: there were statistically significant increases in the counts of all cell lines studied, more pronounced after 12 months of use of the medication.
CONCLUSION: the Transfer Factor restored immune response and showed no side effects.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app